Ms. Steinway will serve as a member of the company’s audit committee, the company said Dec. 14. Ms. Steinway has over 15 years of experience in the medical device industry.
Currently, she is the vice president of strategy, business development and private label at Integra Lifesciences, where she’s worked since 2009. Before that, Ms. Steinway worked as a securities analyst for medical devices and diagnostics equity research at Oppenheimer & Co.
She is a member of the board at ProduceGood, an organization dedicated to finding sustainable solutions to alleviate hunger, reclaim and repurpose waste and promote community health.
With the appointment of Ms. Steinway, the SeaSpine board of directors now consists of nine directors, eight of whom are independent, the company said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.